Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuroone Medical Technologies (NMTC) Non Operating Income (2020 - 2025)

Neuroone Medical Technologies filings provide 8 years of Non Operating Income readings, the most recent being $19058.0 for Q1 2025.

  • On a quarterly basis, Non Operating Income fell 38.54% to $19058.0 in Q1 2025 year-over-year; TTM through Mar 2025 was $77062.0, a 47.81% decrease, with the full-year FY2024 number at $125179.0, up 30.72% from a year prior.
  • Non Operating Income hit $19058.0 in Q1 2025 for Neuroone Medical Technologies, up from $9408.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $83387.0 in Q2 2021 to a low of -$26909.0 in Q1 2023.
  • Median Non Operating Income over the past 4 years was $26376.0 (2024), compared with a mean of $25725.7.
  • The widest YoY moves for Non Operating Income: up 215.23% in 2024, down 79.36% in 2024.
  • Neuroone Medical Technologies' Non Operating Income stood at $83387.0 in 2021, then tumbled by 45.35% to $45575.0 in 2023, then tumbled by 79.36% to $9408.0 in 2024, then soared by 102.57% to $19058.0 in 2025.
  • The last three reported values for Non Operating Income were $19058.0 (Q1 2025), $9408.0 (Q4 2024), and $22220.0 (Q3 2024) per Business Quant data.